Health Canada has approved two new buildings at Hydropothecary’s Gatineau facilities and granted the pot producer a licence renewal to grow and sell as much cannabis as it can store.
The new licence is valid until October 2019, and allows Hydropothecary Corp. (TSX-V:THCX) to grow as much medical marijuana as it can store, as well as removing all restrictions on the quantity of dried marijuana, oil, seeds and plants it can sell.
“An unlimited sales licence from Health Canada positions Hydropothecary for strong future growth. We are very pleased to be amongst the first licensed producers to be granted an expanded licence,” said CEO and co-founder Sebastien St-Louis in a statement.
OBJ360 (Sponsored)
How to mitigate AI legal risks by asking the right questions
Does AI hallucinate? According to local employment law expert Zoriana Priadka of Emond Harnden, it does. Find out how to mitigate your risk as an employer.
Why a backyard coach house could be your quickest route to a new home
Building a backyard coach house is easier thanks to Bill 23, and Ottawa General Contractors are helping home owners make it happen.
Health Canada also approved two new buildings for the company’s Gatineau campus, which the company says will allow it to expand its sales team and order packing facilities. The firm currently has 42,000 square feet of space, which allows it to produce up to 3,600 kilograms of cannabis annually.
Hydropothecary made its debut on the TSX Venture Exchange in March through a reverse takeover of an existing capital pool corporation. Shares of the firm began trading at $1.52 and have since reached a high of $2.90 in April. Prices have dipped since then, opening back down at $1.54 on Thursday morning.
